The Asia Pharma Expo 2025 & Asia Lab Expo 2025, a premier international pharmaceutical trade platform in the region, is set to be held at the BBCFEC, Purbachal, Dhaka from February 12-14, 2025. This event serves as a remarkable opportunity to delve into cutting-edge pharma manufacturing technologies, enhancing Bangladesh’s standing in the global pharmaceutical industry.
Jointly organized by the Bangladesh Association of Pharmaceutical Industries (BAPI) and Gpe Expo Pvt Ltd, this expo celebrates 23 years of fruitful industry collaborations, significantly contributing to the swift growth of Bangladesh’s pharmaceutical sector. Over 800 companies from more than 32 countries will showcase advanced solutions in pharmaceutical processing, packaging, ingredients (APIs, Excipients), lab equipment, cleanroom tech, and more.
Ranked among Asia’s largest pharma exhibitions, the Asia Pharma Expo 2025 aims to bridge international exhibitors with over 12,000 regional trade visitors. The exhibition will offer insights into the shifting landscape of manufacturing, enabling companies to expand operations and enhance technologies to satisfy both local and global demands.
Since its inception in 2003, the Bangladesh Association of Pharmaceutical Industries and Gpe Expo Pvt Ltd have collaboratively organized Asia Pharma and Asia Lab Expo—renowned international exhibitions held in Dhaka, Bangladesh. These events provide a unique global business and technology platform tailored for entrepreneurs and major corporations producing and exporting pharmaceutical medicines worldwide. These expositions even promote growth by equipping local pharmaceutical and related manufacturing industries with technological insights for expanding production capabilities. A profound interest was noted from both domestic business partners and international technology solution providers.
Bangladesh’s pharmaceutical industry has become a pivotal economic contributor on both domestic and international fronts. With more than 300 local manufacturers meeting 98% of national medicinal requirements, the industry has experienced significant growth in recent years. Valued at around US$ 3 billion, Bangladesh’s pharmaceutical industry is burgeoning, with exports reaching over 150 countries. The market size is poised to exceed US$ 6 billion by 2025, with exports anticipated to surpass US$ 450 million.
Benefiting from WTO/TRIPS exemptions, Bangladesh’s local companies enjoy the liberty to produce patented drugs until 2033. This advantage has paved the way for Bangladesh to establish itself as a vital entity in the global pharmaceutical market. Additionally, the advent of the API Manufacturing Park near Dhaka represents a crucial development aimed at curtailing reliance on imported raw materials, consequently bolstering the local pharmaceutical framework.
The Asia Pharma Expo & Asia Lab Expo 2025 presents an unparalleled occasion for international and local enterprises to explore partnerships, innovations, and business prospects within this evolving field. A promising development is the upcoming launch of over 47 units at the API Manufacturing Park near Dhaka.
For detailed information on the exhibition, visit [www.AsiaPharma.org](http://www.asiapharma.org) or email [[email protected]](mailto:[email protected]).